These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29684996)

  • 21. Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?
    Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Frydas I; Theoharides TC
    Inflamm Res; 2018 Sep; 67(9):747-755. PubMed ID: 29961151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional characterization of histamine H4 receptor on human mast cells.
    Jemima EA; Prema A; Thangam EB
    Mol Immunol; 2014 Nov; 62(1):19-28. PubMed ID: 24934979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients.
    Mendieta D; De la Cruz-Aguilera DL; Barrera-Villalpando MI; Becerril-Villanueva E; Arreola R; Hernández-Ferreira E; Pérez-Tapia SM; Pérez-Sánchez G; Garcés-Alvarez ME; Aguirre-Cruz L; Velasco-Velázquez MA; Pavón L
    J Neuroimmunol; 2016 Jan; 290():22-5. PubMed ID: 26711564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances.
    Ortega E; García JJ; Bote ME; Martín-Cordero L; Escalante Y; Saavedra JM; Northoff H; Giraldo E
    Exerc Immunol Rev; 2009; 15():42-65. PubMed ID: 19957871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells.
    Xue L; Gyles SL; Wettey FR; Gazi L; Townsend E; Hunter MG; Pettipher R
    J Immunol; 2005 Nov; 175(10):6531-6. PubMed ID: 16272307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.
    Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
    Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical role of inflammatory mast cell in fibrosis: Potential therapeutic effect of IL-37.
    Conti P; Caraffa A; Mastrangelo F; Tettamanti L; Ronconi G; Frydas I; Kritas SK; Theoharides TC
    Cell Prolif; 2018 Oct; 51(5):e12475. PubMed ID: 30062695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines.
    Tettamanti L; Kritas SK; Gallenga CE; D'Ovidio C; Mastrangelo F; Ronconi G; Caraffa Al; Toniato E; Conti P
    J Biol Regul Homeost Agents; 2018; 32(5):1061-1065. PubMed ID: 30334399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of mold on mast cell-cytokine immune response.
    Kritas SK; Gallenga CE; D Ovidio C; Ronconi G; Caraffa Al; Toniato E; Lauritano D; Conti P
    J Biol Regul Homeost Agents; 2018; 32(4):763-768. PubMed ID: 30043558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL-37.
    Conti P; Caraffa A; Ronconi G; Kritas SK; Mastrangelo F; Tettamanti L; Theoharides TC
    Eur J Pharmacol; 2018 Jan; 818():294-299. PubMed ID: 28970014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mast cells in chronic inflammation, pelvic pain and depression in women.
    Graziottin A; Skaper SD; Fusco M
    Gynecol Endocrinol; 2014 Jul; 30(7):472-7. PubMed ID: 24811097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of mast cells mediates inflammatory response in psoriasis: Potential new therapeutic approach with IL-37.
    Conti P; Gallenga CE; Ronconi G; Caraffa A; Kritas SK
    Dermatol Ther; 2019 Jul; 32(4):e12943. PubMed ID: 31012218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members.
    Robuffo I; Toniato E; Tettamanti L; Mastrangelo F; Ronconi G; Frydas I; Caraffa Al; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2017; 31(4):837-842. PubMed ID: 29254286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial.
    Conti P; Ronconi G; Kritas SK; Caraffa A; Theoharides TC
    Can J Diabetes; 2018 Oct; 42(5):568-573. PubMed ID: 29885882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proinflammatory and Th2-derived cytokines modulate CD40-mediated expression of inflammatory mediators in airway epithelia: implications for the role of epithelial CD40 in airway inflammation.
    Propst SM; Denson R; Rothstein E; Estell K; Schwiebert LM
    J Immunol; 2000 Aug; 165(4):2214-21. PubMed ID: 10925309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokines and depression in cases with fibromyalgia.
    Gür A; Karakoç M; Nas K; Remzi ; Cevik ; Denli A; Saraç J
    J Rheumatol; 2002 Feb; 29(2):358-61. PubMed ID: 11838856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels.
    Kadetoff D; Lampa J; Westman M; Andersson M; Kosek E
    J Neuroimmunol; 2012 Jan; 242(1-2):33-8. PubMed ID: 22126705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inflammatory hypothesis of mood spectrum broadened to fibromyalgia and chronic fatigue syndrome.
    Dell'Osso L; Bazzichi L; Baroni S; Falaschi V; Conversano C; Carmassi C; Marazziti D
    Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S109-16. PubMed ID: 25786052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome.
    Theoharides TC; Tsilioni I; Bawazeer M
    Front Cell Neurosci; 2019; 13():353. PubMed ID: 31427928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4.
    Nelissen S; Vangansewinkel T; Geurts N; Geboes L; Lemmens E; Vidal PM; Lemmens S; Willems L; Boato F; Dooley D; Pehl D; Pejler G; Maurer M; Metz M; Hendrix S
    Neurobiol Dis; 2014 Feb; 62():260-72. PubMed ID: 24075853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.